TOKYO -- Meiji Seika Pharma will partner with the government-affiliated Riken research institute to develop treatments to regrow lost hair, eyeing a full-fledged entry into the booming regenerative medicine field.
The Meiji Holdings unit will work mainly with Takashi Tsuji, head of the Laboratory for Organ Regeneration at the Riken Center for Developmental Biology. Tsuji is known for using stem cells to regrow hair and teeth in mice. During the three-year partnership, Meiji Seika Pharma will test whether his research is applicable to humans and, if so, whether it can be commercialized.
